Trxade Group Inc (MEDS) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Trxade Group Inc (MEDS) has a cash flow conversion efficiency ratio of 0.358x as of June 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($4.22 Million) by net assets ($11.79 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Review MEDS FCF to total liabilities ratio to assess the company's free cash flow relative to its total liabilities.
Trxade Group Inc - Cash Flow Conversion Efficiency Trend (2006–2023)
This chart illustrates how Trxade Group Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Also see MEDS company net worth for the company's overall valuation and market capitalisation.
Trxade Group Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Trxade Group Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Mobi724 Global Solutions Inc
V:MOS
|
0.023x |
|
Sherborne Investors Guernsey C Ltd
LSE:SIGC
|
-0.005x |
|
Sino Hua-An International Bhd
KLSE:2739
|
0.135x |
|
DecideAct A/S
CO:ACT
|
-1.946x |
|
4GLOBAL LS-01
F:HS9
|
N/A |
|
M N C Wireless Bhd
KLSE:0103
|
0.187x |
|
VR Resources Ltd
V:VRR
|
-0.026x |
|
Biophytis S.A.
PA:ALBPS
|
0.472x |
Annual Cash Flow Conversion Efficiency for Trxade Group Inc (2006–2023)
The table below shows the annual cash flow conversion efficiency of Trxade Group Inc from 2006 to 2023. View MEDS live share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-12-31 | $542.35K | $-2.07 Million | -3.823x | +14.09% |
| 2022-12-31 | $342.87K | $-1.53 Million | -4.450x | -553.85% |
| 2021-12-31 | $3.77 Million | $-2.57 Million | -0.681x | -166.73% |
| 2020-12-31 | $8.68 Million | $-2.21 Million | -0.255x | -845.21% |
| 2019-12-31 | $4.14 Million | $141.78K | 0.034x | -89.42% |
| 2018-12-31 | $844.67K | $273.39K | 0.324x | +158.81% |
| 2017-12-31 | $-311.93K | $171.67K | -0.550x | -148.11% |
| 2016-12-31 | $-1.15 Million | $-1.31 Million | 1.144x | +125.41% |
| 2015-12-31 | $267.02K | $-1.20 Million | -4.502x | -182.68% |
| 2014-12-31 | $668.44K | $-1.06 Million | -1.593x | +75.32% |
| 2013-12-31 | $130.87K | $-844.58K | -6.454x | +30.83% |
| 2012-12-31 | $17.48K | $-163.12K | -9.330x | -1690.46% |
| 2008-12-31 | $-48.01 Million | $-28.16 Million | 0.587x | -32.41% |
| 2007-12-31 | $-18.51K | $-16.07K | 0.868x | +234.87% |
| 2006-12-31 | $9.67K | $-6.22K | -0.644x | -- |
About Trxade Group Inc
TRxADE HEALTH, Inc. operates as health services IT company. It offers an online web-based buying and selling platform for licensed pharmaceutical wholesalers to sell brand, generic, and non-drug products and services to government organizations, hospitals, clinics and independent pharmacies. TRxADE HEALTH, Inc. is headquartered in Tampa, Florida.